Over 80 Lawsuits in the UK Allege Astrazeneca COVID Vaccine Linked to Deaths and Severe Injuries

Spread the love

Ongoing legal battles in the U.K. are poised to influence the outcome of a class-action suit against AstraZeneca, with more than 80 individuals alleging injuries caused by the pharmaceutical company’s COVID-19 vaccine. These two lawsuits are functioning as test cases for the larger legal action.

One of the test cases involves Jamie Scott, a father of two who suffered permanent brain injury due to blood clots triggered by the AstraZeneca vaccine in April 2021. The Oxford-AstraZeneca COVID-19 vaccine has been labeled as “defective” in this case, potentially challenging claims about its efficacy.

The second test case revolves around the death of 35-year-old Alpa Tailor, who passed away after receiving the AstraZeneca vaccine. These lawsuits mark the first instances in England and Wales related to adverse reactions to a COVID-19 vaccine.

The VITT Litigation Group, consisting of 80 claimants, has initiated a crowdfunding campaign to address what they consider AstraZeneca’s negligence in acknowledging and compensating for vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT) injuries. The claimants are pursuing legal action under the Consumer Protection Act 1987 and seeking payment through the government-run Vaccine Damage Payment Scheme.

See also  Do the COVID Vaccines Affect Your Ability to Think?

Alex Mitchell, one of the claimants and an amputee suffering from VITT, expressed relief that the lawsuits are progressing. He emphasized the nearly three-year wait for justice and highlighted the physical and mental toll of the vaccine-induced condition.

The Telegraph revealed figures from the U.K.’s Medicines & Healthcare products Regulatory Agency, indicating 81 suspected deaths linked to adverse reactions from the AstraZeneca vaccine, with almost 1 in 5 resulting in fatalities. The Vaccine Damage Payment Scheme received 622 claims related to the AstraZeneca vaccine out of a total of 4,017 COVID-19 vaccine injury claims as of March 6.

Dr. Joel Wallskog, co-chairman of REACT19, a nonprofit advocacy group for vaccine injury victims, welcomed the lawsuits, expressing optimism that such litigation might raise awareness and lead to fair compensation.

Brianne Dressen, co-founder of REACT19 and an AstraZeneca vaccine injury victim, emphasized the importance of these cases in shedding light on the severe human impact of vaccine harms. She criticized the need for individuals to resort to legal action and highlighted the shortcomings of U.S. protections for vaccine injury victims.

See also  Second Case of BA.2.86 COVID Variant Detected in US: Traveler From Japan Becomes Infected With Mutant Strain in Virginia - As Experts Say Case Is Just the Tip of the Iceberg

Dr. Pierre Kory, President of the Front Line COVID-19 Critical Care Alliance, expressed hope that these cases could set a precedent for justice and compensation for vaccine-injured individuals. Charlene Bollinger, founder and CEO of The Truth About Vaccines, welcomed the news, seeing it as a step towards justice for those who suffered due to the alleged misconduct of pharmaceutical companies.

Cardiologist Dr. Peter McCullough raised concerns about the AstraZeneca and Johnson & Johnson vaccines, pointing out similarities in their technology and adverse event profiles. The article also delves into specific cases of vaccine-related injuries, deaths, and the legal complexities involved.

The lawsuits against AstraZeneca bring attention to questions about the U.K. government’s awareness of vaccine risks, with revelations from the “Lockdown Files” suggesting early concerns about the AstraZeneca vaccine. The article concludes by emphasizing the human toll behind each statistic and the potential implications of these legal battles for public awareness and justice.

See also  New Study Claims COVID mRNA Vaccines Resulted in 3.5 Times More American Deaths Than the Virus Itself

Read more at childrenshealthdefense.org

Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *